2026 International Congress Archives - Page 151 of 208

Caffeine and Tobacco Exposure and the Presence of Levodopa-Induced Dyskinesia (LID) in the STAT-PD Trial

A. Clarke, B. Lobb, K. Chung (Portland, USA)
Calcification Foci Caused by Gene Defects in Primary Brain Calcification May Originate from Matrix Vesicle

X. Jin, L. Wang, W. Luo (Zhejiang, China)
Can a slogan poster featuring the patient’s primary physician help improve gait and prevent falls at home in patients with Parkinson’s disease?

Y. Okuma (Izunokuni, Japan)
Can digital Mobility Outcomes differentiate cognitive impairment in Parkinson’s Disease?

P. Ginis, D. Muzyka, V. Shah, L. Alcock, C. Schlenstedt, C. Becker, J. Buekers, B. Caulfield, C. Hansen, S. Del Din, L. Delgado-Ortiz, J. Garcia-Aymerich, H. Gassner, A. Nieuwboer, J. Hausdorff, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall (Philadelphia, USA)
Can Parkinson’s Disease and Progressive Supranuclear Palsy be Distinguished Using Surgical Planning Image Analysis Software?

K. Matsuura, A. Nishigaki, S. Horie, K. Sakae, T. Utsunomiya, K. Miyashita, K. Tabei, A. Shindo (Tsu, Mie, Japan)
Can people with Parkinson’s disease improve gait adaptation skills via upregulation of the posterior parietal cortex?

T. Ogawa, C. Guedes, C. Mvomo, L. Hajjaji, J. Bedime, A. Potvin-Desrochers, C. Paquette (Montreal, Canada)
Can Prayer Beads Quantify Bradykinesia? An Ultra-Low-Cost Approach to Motor Assessment in Parkinson’s Disease

N. Raisa, B. Perwirayuda, SB. Rianawati, AC. Pratiwi (Malang, Indonesia)
Can Voice Therapy Improve Swallowing in Advanced Parkinson’s Disease? A Comparison of SPEAK OUT!® Outcomes in Patients With Deep Brain Stimulation and Medical Therapy

N. Likhitwitayawuid, S. Jitwiriyanont, K. Nantanukul, R. Bhidayasiri, O. Phokaewvarangkul (Bangkok, Thailand)
Cannabis-based Oil for Pain and Other Non-motor Symptoms in Parkinson’s Disease: a Randomized Controlled Trial

A. Alves, J. Parmera, G. Kubota, P. Martins, M. Deltreggia, A. Falcone, A. Santana, M. Falcão, M. Dias, L. Moreira, P. Filho, E. Figueiredo, E. Barbosa, R. Cury, D. Andrade (Juiz de Fora, Brazil)
Cardiac Pacing Strategies for Cardiovascular Autonomic Dysfunction in Parkinson’s Disease

Y. Cordes, T. Fischer, J. Volkmann (Würzburg, Germany)
Cardiovascular Autonomic Dysfunction and Cognitive Impairment in Parkinson’s Disease: A Systematic Review

M. Kakde, S. Kakde, S. Kakade (Pune, India)
Caregiver Burden in Advanced versus Non-Advanced Parkinson’s Disease: Strain and Health-Related Quality of Life

S. Ruohonen, M. Ranta, M. Kalaoja, I. Iso-Mustajärvi, V. Kaasinen (Helsinki, Finland)
Case of Head Drop as an Adverse Drug Reaction to Dopamine Agonists and Regulatory Evaluation

AK. Stark, P. Mcgettigan, HB. Biernat, A. Lokkegaard (Copenhagen NV, Denmark)
Categorization and Characterization of Cognitive Phenotypes in Parkinson’s Disease Using Machine Learning.

H. Trujillo-Guerra, R. Trejo-Ayala, P. Téllez-Hernández, J. Esquivel-Del Río, B. Chávez-Luévanos, I. Estrada-Bellmann, X. Ortiz-Jiménez (Monterrey, Mexico)
Caudate-Predominant Striatal Dopaminergic Deficits in bvFTD with Parkinsonism

L. Feng, W. Liu, J. Wang, J. Wang, F. Liu (Shanghai, China)
Causes of Death and Clinical Predictors of Mortality in Parkinson’s Disease and Parkinsonism: A 30-Year Population-Based Study

F. Onorati, L. Malfer, A. Mullan, R. Savica (Rome, Italy)
Cell-type-specific asynchronous aging acceleration across movement disorders

X. Chen, W. Du, J. Luo, G. Liu (Shenzhen, China)
Central Autonomic Network Alterations in MSA: From Subcortical Degeneration to Prefrontal Reorganization

Y. Wang, A. He, W. Mao, P. Chen (Beijing, China)
Central Nervous System Lesioning Procedures For Dystonia In The Deep Brain Stimulation Era: A Systematic Review

L. Santos, I. Lera, C. Ordás-Bandera, H. Canfield, A. Querejeta-Coma (Madrid, Spain)
Cerebellar cholinergic denervation relates to impaired gait and cerebellocortical resting-state functional connectivity in Parkinson disease

B. Maiti, J. O'Donnell, K. Rawson, M. Owusu-Ansah, A. Tannenbaum, A. Eid, S. Grossen, J. Hood, S. Norris, M. Campbell, G. Earhart, J. Perlmutter (Saint Louis, USA)
Cerebellar Network Compensation in Parkinson’s Disease: Functional Connectivity Across Motor and Cognitive Circuits

C. Lin, T. Magalhães, S. Yonce, I. Rampalli, R. Mahabir, J. Bernard (Houston, USA)
Cerebellar Non-Invasive Brain Stimulation for Tremor Reduction in Essential Tremor: Systematic Review and Meta-Analysis of Randomized Controlled Trials

A. Gunasekar, T. Lalotra, S. Nair, S. Khankar, N. K, R. Velusamy, A. Dey, R. Ramananthan, J. Srirangaramasamy, B. Kamaraj (Thiruvallur, India)
Cerebellar peduncle microstructure and autonomic dysfunction in Parkinson’s disease

RY. Yang, YUZ. Zhang (Guangzhou, Guangdong Province, China)
Cerebellar Variant of Progressive Supranuclear Palsy: First Case Report from Peru

FA. Arroyo-Ramirez, M. Alvarado-Morales, J. Gutierrez-Arratia, B. Oporto-Arenas, L. Zelada-Rios, M. Vélez-Rojas, L. Torres-Ramirez (Lima, Peru)
Cerebellar α-Synucleinopathy Contributes to Gait and Balance Impairment in Parkinson’s Disease

T. Li, Q. Qiu (Dalian, China)
Cerebellar-Basal Ganglia Circuitry in the Pathogenesis of Parkinsonian Postural Instability

O. Alenikova, A. Chumak, L. Parkhach (Minsk, Belarus)
Cerebellar-cortical-spinal information flow for motor kinematic control

YM. Wang, KC. Fang, TY. Liang, MK. Pan (Taipei, Taiwan)
Cerebral Small Vessel Disease Associated with Clinical Heterogeneity in Vascular Parkinsonism

Y. Li, P. He, L. Wang, K. Nie (Guangzhou, Guangdong Province, China)
Cerebral Small Vessel Disease Burden and Motor Phenotype Expression in Parkinsonian Syndromes: A Quantitative Neuroimaging Analysis

FAY. Mallaev, GUL. Rakhimbaeva (Tashkent, Uzbekistan)
Cerebral Small Vessel Disease-Related Degeneration of Cholinergic Pathways Contributes to Cognitive Impairment in Parkinson’s Disease

SM. Rong, XL. Cui, R. Yang, ZH. Li, YH. Zhang, MF. Cai (Guangzhou, Guangdong Province, China)
Cerebrospinal Fluid Markers are associated with Cognitive Decline in GBA1-associated Parkinson’s Disease

M. Bode, C. Schulte, S. Becker, I. Wurster, B. Roeben, S. Lerche, W. Poewe, K. Brockmann, I. Liepelt-Scarfone (Tübingen, Germany)
Cerebrospinal Fluid Metabolic Alterations Reveal a Central Energy Metabolism Shift in Parkinson’s Disease

R. Nagao, Y. Mizutani, R. Ohdake, Y. Maeda, J. Yoshimoto, K. Kawabata, S. Shima, Y. Seino, M. Ito, A. Suzuki, H. Watanabe (Toyoake, Japan)
Cerebrovascular reactivity in Parkinson’s disease: acute effects of Levodopa assessed by transcranial doppler

F. Garramone, D. Rinaldi, I. Madonia, M. Sforza, V. Teresi, E. Bianchini, L. de Carolis, S. Galli, P. Pacilio, P. Lombardo, M. Salvetti, G. Sette (Rome, Italy)
Cervical Dystonia: The Objective Evaluation Of Muscle Tone

M. Falletti (Rome, Italy)
Challenges of Translating the MDS-UPDRS into Ukrainian During Wartime

TV. Voloshyn, IP. Popovych, NM. Melekh, OK. Kachmar (TRUSKAVETS, Ukraine)
Challenging Traditional Paradigm: Clinical Outcomes of Early vs Late Subthalamic Deep Brain Stimulation in Parkinson’s Disease

BC. Ari, M. Cakmak, Y. Ekmis, E. Adiguzel, N. Helvaci Yilmaz, Y. Samanci, G. Kenangil, A. Lozano, A. Zirh (Toronto, Canada)
Changes in ADL-Related Factors According to Disease Stage in Patients with Parkinson’s Disease: Multiple Regression Analysis

K. Watanabe, T. Nakamura, G. Horiguchi, H. Miyamoto, Y. Yamazaki, Y. Kameyama, E. Kitahara, K. Haruyama, N. Nishikawa, T. Hatano, N. Hattori, T. Fujiwara (Bunkyo-ku, Japan)
Changes in Continuous Good ON and Best ON Time During the Waking Day With Tavapadon in People With Parkinson’s Disease

R. Hauser, R. Dhall, D. Kremens, L. Harmer, K. Chan, J. Ma (Tampa, USA)
Changes in CSF dynamics and regional brain activation following CSF drainage in normal pressure hydrocephalus: A combined 7T fMRI and 3T Cine MRI pilot study

H. Chang, S. Kim, H. Heo, S. Oh, S. Tak, E. Oh (Daejeon, Republic of Korea)
Changing the ‘Game’: The Impact of ‘Serious Games’-based Cognitive Training on Cognitive Function in Parkinson’s Disease

M. Homes-Vickers, A. Mcnamara, A. Leonard, D. Hobbs, L. Collins-Praino (Adelaide, Australia)
Characterisation of early onset Parkinson’s disease in UK cohorts

E. Lam, J. Frost, M. Fenn, S. Jasaityte, N. Kuznetsov, L. Lange, D. Vitale, D. Grosset, N. Williams, R. Real, H. Morris (London, United Kingdom)
Characterising Consent and Engagement with Remote Blood Collection in PREDICT-PD

S. Meyer, B. Huxford, H. Chohan, A. Shahid, R. Lathey, S. Waters, L. Smith, C. Simonet, L. Pérez-Carbonell, E. de Pablo-Fernandez, A. Schrag, A. Noyce (London, United Kingdom)
Characterising immune changes in the nose in Parkinson’s disease

C. Tournerie, B. Patel, M. Camacho, A. Friend, M. Schaepers, W. Woods, C. Williams-Gray (Cambridge, United Kingdom)
Characteristics and Outcomes of Hospitalisation Episodes for Australians living with Parkinson’s Disease

S-E. Soh, M. Callisaya, V. Mcconvey, K. Bower, A. Terrens, M. Klaic, A. Vogel, J. Mcginley (Melbourne, Australia)
Characteristics And Progression Of Non-Motor Symptoms In Parkinsons Disease

A. Shalash, M. Salama, M. Essam, Y. Mahran, E. Hamid, A. Helmy (Cairo, Egypt)
Characteristics of Cortical Beta Bursts in Parkinson’s disease

L. Witt, L. Chen, S. He, A. Pogosyan, L. Timmermann, H. Tan, D. Pedrosa, P. Loehrer (Marburg, Germany)
Characteristics of participants of the Australian National Disability Insurance Scheme with Parkinson’s disease

J. Mcginley, K. Bower, V. Mcconvey, M. Callisaya, A. Khan, M. Ho, D. Shen, S. Fernando, M. Klaic, S. Soh (Parkville, Australia)
Characterizing Gastrointestinal Dysfunction and its Psychosocial Associations in Idiopathic Parkinson’s Disease: Findings from a Single centre Prospective Cross-sectional Indian study

A. Janardhan, A. Mehta, P. Hiremath, P. R, L. R, M. Javali, P. Acharya (Bengaluru, India)
Characterizing Local Field Potentials in Early-Onset Dystonia

P. Bisarad, A. Shrestha, K. Shivaram, H. Magee, R. Gelineau-Morel, C. Gorodetsky, S. Hallgren, A. Hewitt, G. Ibrahim, J. Kelbert, T. Larsh, N. Lucente, J. O'Malley, M. Pascual, S. Wu, F. Ponce, J. Hauptman, D. Kern, J. Thompson, M. Kruer (Phoenix, USA)
Characterizing Longitudinal Motor Progression in Parkinson’s Disease leveraging Digital Health Technologies in L-DOPA ON and OFF States

S. Lambrecht, Y. Gazizova, F. Lipsmeier, W. Popp, B. Fehlmann, T. Nikolcheva, N. Pross, M. Lindemann, K. Taylor (Basel, Switzerland)
Characterizing Movement Disorders in Niemann-Pick Disease Type C -A Registry-Based Analysis with Findings from the International Niemann-Pick-Disease Registry (INPDR)

A. Menetrey, A. Ambrad, S. Bolton, N. Martin, M. Inbar-Feigenberg, C. Gorodetsky (Washington, United Kingdom)
CHCHD2 Exonic Deletion in a Chilean Parkinson’s Disease Patient: First Latin American Report

E. Fernandez-Toledo, M. Valenzuela, P. Saffie-Awad (Santiago, Chile)
Childhood-onset Dystonia Linked to KIF5A:p.Arg422Cys: Case Report and Functional Characterization

P. Lorenzo-Barreto, R. Repossi, I. Muro, E. Casas, S. López-Llorente, V. Hernando-Requejo, L. Ballesteros-Plaza, J. Hoenicka, L. López-Manzanares (Madrid, Spain)
Childhood-Onset Parkinsonism with Prominent Pyramidal Signs: A Complex Neurogenetic Phenotype

D. Munoz-Chesta, F. Acuña, M. Troncoso (Santiago, Chile)
Childhood-Onset Spastic Paraparesis Followed by Early-Onset Parkinsonism: A Genetically Unresolved Case of Complicated Hereditary Spastic Paraplegia

I. Sarac, H. Sarac, F. Borovecki, N. Henigsberg (Zagreb, Croatia)
Chinese Expert Consensus and Recommendations on Sensing-guided Deep Brain Stimulation for Parkinson’s Disease: A Modified Delphi Study

F. Liu, J. Wang, S. Mei, P. Li, W. Song, L. Qiao, J. Wang (Shanghai, China)
Cholinergic Basal Forebrain Atrophy Associates with Short-Latency Afferent Inhibition and Cognitive Impairment in Parkinson’s Disease

JF. Martín-Rodríguez, P. Franco-Rosado, C. Perez-Calvo, E. Iglesias-Camacho, M. San-Eufrasio, A. Castellano-Guerrero, FJ. Gómez-Campos, P. Díaz-Galván, MA. Labrador-Espinosa, J. Silva-Rodríguez, AC. Luque Ambrosiani, E. Ojeda-Lepe, L. Muñoz-Delgado, D. Macías-García, A. Adarmes-Gómez, S. Jesus, F. Carrillo, F. Roldan Lora, MJ. Grothe, P. Mir (Sevilla, Spain)
Cholinergic Dysconnectivity in Early Parkinson’s Disease Aligns with the Basal Forebrain Functional Gradient

A. Ignatavicius, L. Churchill, A. Konuri, J. Anderson, S. Lewis, E. Matar (Macquarie Park, Australia)
Cholinergic dysfunction associated to aberrant functional connectivity in Parkinson Disease-related dystonia

L. Xavier, A. Morris, N. Goldman, J. O’Donnell, A. Magee, A. Eid, H. Hwang, J. Perlmutter, M. Campbell, S. Norris (Saint Louis, USA)
Cholinergic Pathway Degeneration Predicts Differential Phenoconversion to Synucleinopathies in Idiopathic REM Sleep Behavior Disorder

D. Zhang, T. Wu (Beijing, China)
Cholinergic Systems Changes Associated with Freezing of Gait in Progressive Supranuclear Palsy

P. Kanel, G. Carli, S. Roytman, J. Barr, R. Vangel, A. van Hout, C. Spears, P. Scott, R. Albin, N. Bohnen (Ann. Arbor, USA)
Choreoathetosis revealing vitamin B12 deficiency : an unusual manifestation of subacute combined degeneration

O. Sakli, R. Zouari, A. Rachdi, Z. Saied, F. Nabli, D. Ben Mohamed, S. Ben Sassi (Tunis, Tunisia)
Choroid Plexus Morphology and Enhancement as Imaging Markers for Early Differentiation of Multiple System Atrophy and Parkinson’s Disease

S. Jo, D. Ambaye, M. Choi, G. Lee, S. Chung, E. Lee, H. Cho (Seoul, Republic of Korea)
Chronic Vanadium Exposure Promotes Memory Impairment and Aggregation of Alpha-Synuclein, Tau and Amyloid Beta in Mouse Brain

O. Folarin, F. Olopade, T. Gilbert, A. Ladagu, P. Inês, O. Mustapha, L. Zethan, J. Olopade, T. Outeiro (Ibadan, Nigeria)
Circadian Regulator REV-ERBα Drives Microglial Lipid Metabolic Reprogramming and Cognitive Impairment in Parkinson‘s Disease

T. Deng (Guang Zhou, China)
Circuit Malfunctions Undetectable by DBS Programmers: Role of Intraoperative Direct Measurement of Impedance

J. Ikezawa, A. Isoo, H. Kashii, F. Yokochi, T. Kawasaki, K. Watanabe, T. Agari, A. Yugeta, R. Okiyama, K. Takahashi, S. Kumada (Tokyo, Japan)
Classification of Fallers in Parkinson’s Disease Through Machine Learning Based Feature Analysis

SM. Kim, MK. Kim, MJ. Chung, JW. Cho, HJ. Yoo, JY. Youn (Seoul, Republic of Korea)
Clinical Analysis of Progressive Supranuclear Palsy in Sri Lanka: Preliminary Results from a Cross-Sectional Collaborative Study with Global Parkinson’s Genetic Program (GP2)

A. Pathirage, V. Vithudsha, P. Ruwanpathirana, B. Senanayake (colombo 08, Sri Lanka)
Clinical and Autonomic Correlates of Chronic Sialorrhea in Parkinson’s Disease: A Questionnaire-Based Study with Cluster Analysis of Autonomic and Dysphagia Burden

S. Okusa, R. Okochi, Y. Sakai, T. Nukariya, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)
Clinical and Biomarker Trajectories in GBA1 Non-Manifesting Carriers With and Without α-Synuclein Seed Amplification Positivity

P. Gonzalez-Latapi, S. Brooker, C. Gochanour, M. Brumm, K. Merchant, R. Alcalay, T. Simuni (Chicago, USA)
Clinical and brain morphological characteristics of patients with Parkinson’s disease and co-occurring apathy and impulse control disorders

S. Prange, E. Metereau, M. Bereau, H. Klinger, C. Caire, C. Laurencin, D. Devos, M. Anheim, S. Thobois (Bron, France)
Clinical and Cognitive Profile in Patients with Atypical Parkinsonian Syndromes: A Longitudinal Study from a Tertiary Care Center

R. Kumar, S. Dey, A. K, G. Tv, A. Mohan, M. Harish, V. Holla, N. Kamble, R. Mahale, A. Mehta, P. Mailankody, K. Kumar, M. Debnath, P. Pal, R. Yadav (Bengaluru, India)
Clinical and Functional Outcomes of Antiviral and Immunomodulatory Therapies in Subacute Sclerosing Panencephalitis

S. Errabelly, V. Jadhav, M. Tripathi, D. Dash, P. Mohapatra, E. Arunmozhimaran (New Delhi, India)
Clinical and genetic analysis of Kuwaiti and Saudi families exhibiting CLN5 adult-onset autosomal recessive spinocerebellar ataxia. A potential founder mutation

W. Kamel, H. Alrohaif, M. Almannai, D. Al Mehatab, W. Aljirdrawi, L. Bastaki (Beni-Suef, Egypt)
Clinical and Genetic Characteristics of SACS-Related Ataxia: A Case Series of 13 Patients from a Consanguineous Arab Population

H. Alqahtani, F. Alqahtani, M. Abukhalid, M. Almuhaizea, S. Bohlega, S. Alshimemeri, A. Aldakheel, S. Alqahtani (Riyhadh, Saudi Arabia)
Clinical and Genetic Profile of the ACTIVATE Population: A Phase 2 Trial of BIA 28-6156 in GBA-PD

JJF. Ferreira, RC. Costa, RBM. Bouça-Machado, FRP. Pereira, GC. Cordeiro, TF. Fonseca, MF. Fonseca, DR. Ramos, AG. Guimarães, JH. Holenz (Lisboa, Portugal)
Clinical and genetic profiles of patients with Huntington’s disease and other hereditary choreas: Experience from an Indian Movement Disorder Clinic.

D. Radhakrishnan, A. Sonakar, P. Mandadi, J. George, F. Mustafa, R. Rajan, D. Garg, A. Das, J. Parihar, E. Elavarasi, M. Faruq, A. Srivastava (Delhi, India)
Clinical and Kinematic Assessment of Parkinsonian Features in Young Adults with 22q11.2 Deletion Syndrome

L. Angelini, A. Mazzeo, E. Cerulli Irelli, A. de Core, D. Birreci, AS. Grandolfo, MS. Borioni, S. Aloisio, M. de Riggi, F. Pulvirenti, C. Di Bonaventura, M. Bologna (Rome, Italy)
Clinical and Kinematic Evaluation of a Tremor-Damping Glove in Essential Tremor

RB. Shi, P. Rizek (Mississauga ON, Canada)
Clinical and Mobility Outcome with Ring versus Directional Globus Pallidus Stimulation in Parkinson’s Disease

A. Ragothaman, J. Lee, V. Massicotte, G. Harker, P. Carlson-Kuhta, L. Neilson, C. Zarns, M. Case, R. Vigh, A. Becker, R. Raike, K. Burchiel, M. Mancini, D. Safarpour (Portland, USA)
Clinical and Multimodal Biomarker Profiles in Progressive Supranuclear Palsy: The PSPNI Cohort Study in China

Q. Shen, XY. Li, J. Wang, FT. Liu (Shanghai, China)
Clinical and Patient-Reported Outcomes in Patients With and Without Severe Bradykinesia According to Sensor Measurements

D. von Below, S. Wallerstedt, F. Bergquist (Gothenburg, Sweden)
Clinical and Phenotypic Features of Concurrent Huntington’s Disease and Amyotrophic Lateral Sclerosis: A Case Series

J. Mitzner, D. Lacomis, V. Suski (Pittsburgh, USA)
Clinical and Programming Parameter Comparison of STN and GPi Deep Brain Stimulation Targets in Parkinson’s Disease

H. ömercikoğlu özden, Eç. Hayırlıoğlu, SD. özgüç, D. Günal (İstanbul, Turkey)
Clinical and Psychophysiological Characteristics of Chronic Pain in Parkinson’s Disease: Pain Phenotypes, Central Sensitization, and Quality of Life

B. Alieva, Y. Shpilyukova (Moscow, Russian Federation)
Clinical and Sociodemographic Characteristics of Rural and Urban Individuals Living with Parkinson’s Disease

K. Dyer, D. Shah-Zamora (Winston Salem, USA)
Clinical Approach to Impulse Control–Related Behavioural Disorders in Parkinson’s Disease: A Scoping Review

G. Jin Yi, C. Lai Gwen, F. Cardoso, L. Tan (Singapore, Singapore)
Clinical Characteristics and Functional Impact of Tremor in Patients with Multiple Sclerosis in Nepal: A Cross-Sectional Observational Study

AYU. Chandra, AVI. Chandra (Kathmandu, Nepal)
Clinical Characteristics of Fracture Injury by Falling in Parkinson’s Disease, a Prospective Cohort Study

J. Lee (Seongnam-si, Republic of Korea)
Clinical Characteristics of Gastric Motility Disorder in Early-Stage Parkinson’s Disease and Its Longitudinal Predictive Value for Disease Progression

X-Y. Cheng, J-Y. Jin, C-J. Mao, C-F. Liu (Suzhou, China)
Clinical Characterization and Functional Correlates of Multiple System Atrophy in Sri Lanka: Preliminary Results from a Cross-Sectional Collaborative Study with Global Parkinson’s Genetic Program (GP2)

A. Pathirage, V. Vithudsha, P. Ruwanpathirana, B. Senanayake (colombo 08, Sri Lanka)
Clinical Correlates of Dysphagia in Multiple System Atrophy: A Multicenter Retrospective Study

N. Takahashi, G. Umemoto, J. Tsugawa, K. Kurihara, Y. Baba (Fukuoka, Japan)
Clinical Drug-Drug Interaction Profile Of BIA 28-6156: Results From Three Independent Phase I Studies

TF. Fonseca, AR. Ronaghinia, JR. Reis, DR. Rodrigues, AN. Neves, GC. Cordeiro, RC. Costa, FR. Rocha, DM. Magalhães, AG. Guimarães, JH. Holenz (Coronado, Portugal)
Clinical Effectiveness of Radiofrequency Thermal Ablative Lesioning for the Management of Motor Symptoms in Movement Disorders: Real-World Evidence

J. Vesper, E. Pereira, A. Dreyer, R. Shivacharan, L. Chen, E. Goldberg (Düsseldorf, Germany)
Clinical Evaluation of TT-P34: Exploring Safety and CSF Exposure in Parkinson’s Disease Patients

A. Borta, K. Comassi, S. Singh, E. Browne, A. Dalby, S. Korsten, M. Aaboe Jørgensen, G. Layton, J. Castricum, S. Mølgaard, P. Kremer (Leiden, Netherlands)
Clinical Factors Associated with the Hospitalization of Patients with Parkinson’s Disease: A 3-year Prospective Study

R. Morimoto, K. Todo, M. Iijima (Tokyo, Japan)
Clinical feasibility of a semi-automated Olfactometry System in α-Synucleinopathies

A. Jäck, K. Pusl, L. Schlage, A. Bernhardt, K. Katzdobler, S. Kinoshita, M. Sasaki, T. Hummel, S. Fujita, G. Höglinger, J. Levin (Munich, Germany)
Clinical Features and Trajectories Related to Entacapone Use in Parkinson’s Disease: insights from the French NS Park Cohort

S. Gallo, P. Bastos, JE. Timmermann, M. Fabbri, B. Morlaes, O. Rascol (Toulouse, France)
Clinical Features and Treatment Response in Stiff Person Spectrum Disorder: A Case Series from a Tertiary Neurology Centre

A. Oommen, P. Wadia (Mumbai, India)
Clinical Features of DJ1 Gene Mutation Causing Parkinson’s Disease from a Single Centre

H. Alhodaif, S. Alqahtani, F. Alotaibi, A. Aldakheel, S. Bohlega (Riyhadh, Saudi Arabia)
Clinical Features of Multiple System Atrophy Across Diverse Populations: A Systematic Review of Subtypes and Diagnostic Frameworks

M. Cornejo-Olivas, M. Galecio-Castillo, A. Abad, Y. Nuñez-Coronado, J. Gutierrez-Arratia, C. Alarcon-Ruiz, M. Illanes-Manrique, M. Alfaro-Olivera, C. Armas-Puente, E. Sarapura-Castro, E. Gatto, H. Morris (London, United Kingdom)
Clinical Features of Patients with an Essential Tremor–to–Parkinson’s Disease Diagnostic Trajectory

A. Kuusela, E. Ottela, V. Kaasinen (Turku, Finland)
Clinical features of vascular parkinsonism

R. Juraev, R. Matmurodov, E. Abdukodirov, I. Mukhamedsaidova, S. Jumanazarova (Tashkent, Uzbekistan)
Clinical Gait Traits and Cerebellar-PPN Functional Connectivity Abnormalities in Early and Moderate-to-Advanced PD with Gait Disturbance via Perceptual Technology and MRI

J. Su, D. Liu, J. Shang, L. She, H. Wang, Y. Pan (Wuhan, China)
Clinical impact of local field potential sensing–guided deep brain stimulation: a real‑world registry

J. Youn, S. Bick, P. Konrad, M. Schiess, T. Theys, T. Witt, H. Mure, H. Oshima, K. Kimura, G. Oyama, H. Kishima, N. Murase, Y. Tsuboi, A. Fasano, T. Brionne, I. Buffin, G. Choi, X. Sun, Y. Ren, T. Weaver (Seoul, Republic of Korea)
Clinical Impact of Nicotine in Parkinson’s Disease: Evidence from Randomized Controlled Studies

J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)
Clinical instability and fluctuations as an early marker of accelerated progression

A. Beltrán-Torres, M. Rocha-de-León, K. Sánchez-Ramírez, N. Sánchez-Lorenzo, A. Cervantes-Arriaga, M. Rodríguez-Violante (Monterrey, Mexico)
Clinical Markers of Monogenic Mimics in Atypical Parkinsonism: Findings From a 150-Patient Series

ZD. Cen, YX. Kang, XH. Chen, B. Wang, W. Luo (Zhejiang, China)
Clinical Outcome Assessments for Parkinson’s Disease Psychosis: A Systematic Review

E. Camboe, S. Delray, MHS. Tosin, AJ. Noyce, C. Cooper (London, United Kingdom)
Clinical Outcome Assessments for Psychiatric Manifestations in Dystonia: Systematic Review, Critique, and Recommendations

A. Wagle Shukla, K. Peall, D. Martino, G. Chan, S. Pandey, S. Rafee, V. Voros, M. Tijssen, N. Kovacs, M. Skorvanek (Gainesville, USA)
Clinical Outcome Assessments for Spasticity and Functional Performance in Spastic Paresis: Which Scales Should Be Used?

R. Jech, O. Gál, M. Hoskovcová, JM. Gracies, J. Wissel, C. Rodriguez-Blazquez, M. Baude, B. Biering-Sørensen, R. Rosales, T. Deltombe, L. Satkunam, T. Wein, MHS. Tosin, M. Galea, A. Esquenazi, á. Sánchez-Ferro, T. Mestre, M. Skorvanek (Prague, Czech Republic)
Clinical Outcomes and Predictors of MR-Guided Focused Ultrasound Thalamotomy in Medically Refractory Essential Tremor: Initial Experience in Turkey

ö. Köksal, B. Arı, G. Yılmaz çakan, İ. Emekli, N. Helvacı Yılmaz, G. Kenangil, L. Karşıgil, Y. Samancı, M. Tönge, A. Lozano, A. Zırh (Istanbul, Turkey)
Clinical Outcomes and Safety of Ablative Surgery for Parkinson’s Disease in Resource-Limited Settings: A Cohort from Indonesia

R. Ibonita, A. Sulistyanto, N. Adhitama, R. Puspa, A. Devicaesaria, M. Wedariani, S. Lumempouw (East Jakarta, Indonesia)
Clinical outcomes of deep brain stimulation for Parkinson’s disease in the Dominican Republic: results from a newly established single-center DBS program

W. Massih Montero, M. Espinosa Pérez, A. Segura Peña, V. Torres, A. Carreras, A. Pérez Fernández, K. Del Giudice (Santo Domingo, Dominican Republic)
Clinical Outcomes of Deep Brain Stimulation in Malaysian Children with Pharmacoresistant Dystonia

WK. Lim, ZX. Ching, WHM. Wan Zainuddin, L. Li, CY. Fong, KA. Muthusamy (Kuala Lumpur, Malaysia)
Clinical Outcomes of Globus Pallidus Interna Deep Brain Stimulation in Primary and Secondary Dystonia: A Single-Center Experience

R. Toklu çetinkaya, N. Durmaz çelik, S. özkan (eskişehir, Turkey)
Clinical Outcomes Of Globus Pallidus Internus Deep Brain Stimulation In ADCY5-Related Dyskinesia: A Case Series From A Tertiary Movement Disorders Center

T. Alhawsawi, N. Alenazi, S. Alshimemeri, H. Alhodaif, S. Alqahtani, F. Alotaibi, A. Aldakheel (Riyadh, Saudi Arabia)
Clinical Predictors of Cognitive Decline in Parkinson’s Disease: A Longitudinal Cohort Study

I. Zhukova, M. Matveeva, N. Zhukova, E. Agasheva, D. Novotnyy, S. Shtaymets, Z. Sayfitdinkhuzhaev (Moscow, Russian Federation)
Clinical Profile and Key Correlates of Genetic Load, Motor Severity, and Caregiver Burden in an Iranian Huntington’s Disease Cohort

M. Salari, K. Rezaei, M. Etemadifar (Tehran, Islamic Republic of Iran)
Clinical Profile and Progression of Parkinson’s Disease in Nigerians with the GBA1 African Ancestry-specific Risk Variant

O. Ojo, N. Okubadejo, NPD. Research Network, GP2. Genetics Program (Lagos, Nigeria)
Clinical Profile of Early-Onset Parkinson’s Disease in a Tertiary Hospital in Oman

J. Al Balushi, AL. Aldarmaki, R. Al Bahlani, AZ. Al Makhmari, AH. Al Qassabi (Muscat, Oman)
Clinical Profile, Therapeutic Interventions, and Outcome Predictors of Paraneoplastic Movement Disorders – A Tertiary Care Centre Experience

A. Vijayaraghavan (Thiruvananthapuram, India)
Clinical progression of PSP-Richardson’s syndrome and other PSP variants in an East Asian cohort

SM. Lee, R. Kim, JY. Lee (Seoul, Republic of Korea)
Clinical Relevance of Oral Health Assessment in Parkinson’s Disease Monitoring

R. Naqvi, V. Ha, S. Elshourbagy, A. Valverde, S. Tomar, J. Schwartz, A. Naqvi, P. Engen, M. Shaikh, C. Neumann, M. Villanueva, D. Sanchez-Bass, L. Dibenedetto, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)
Clinical Significance of Automatically Assessed Perivascular Space Count in Subcortical White Matter of Parkinson’s Disease

SJ. Chung, CJ. Park, Y. Nam, YJ. Kim, PH. Lee (Seodaemun-gu, Republic of Korea)
Clinical Significance of Imaging Markers for Cerebellar Ataxia and Parkinsonism in Multiple System Atrophy

Y. Nakano, A. Sugiyama, Y. Nakagawa, M. Tamura, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, K. Osawa, T. Yamamoto, Y. Yamanaka, M. Mori, S. Hirano (Chiba, Japan)
Clinical Spectrum of Atypical Parkinsonian Disorders in Sri Lanka: Preliminary Results from a Global Parkinson’s Genetic Programme (GP2) Collaborative Study

V. Vithudsha, A. Pathirage, P. Ruwanpathirana, B. Senanayake (colombo 08, Sri Lanka)
Clinical Spectrum of Cerebellar Fits in Adults and Children: A Systematic Review

P. Bhatele, P. Kukkle (Bangalore, India)
Clinical Stage According to Hoehn & Yahr Scale as a Predictor of Non-Motor Symptom Severity in Parkinson’s Disease: A Cross-Sectional in Peru

J. Moya-Salazar, A. Sobrino-Galindo, B. Cañari (Chiclayo, Peru)
Clinical study on acupuncture improving anxiety in Parkinson’s disease by regulating the HPA axis

JQ. Fan, WJ. Lu, X. Liu, YT. Wang, LX. Zhuang (Guangzhou, China)
Clinical Underestimation of Wearing-Off in Parkinson’s Disease: Patient-Reported Outcomes Versus Clinical Assessment and Impact on Quality of Life

M. Acharya, A. Debnath (Kharagpur, India)
Clinical Utility of DaT-SPECT as a Predictive Tool for the Development of Parkinson’s Disease and Related ɑ-synucleinopathies in REM-Behavior Disorder

M. Markgraf, H. Bhaskar, O. Lekan-Michael, D. Lubin, M. Lammle (Syracuse, USA)
Clinical Utility of Neurophysiological Tremor Study Within a Joint Neurology-Neurophysiology Movement Disorders Clinic: One-Year Retrospective Two-Center Study

L. Santos, C. Ordás-Bandera, H. Canfield, L. Yupanqui, A. Gómez, A. Querejeta-Coma (Madrid, Spain)
Clinical-Genealogical Analysis of Parkinson’s Disease

M. Ibodullaeva, R. Matmurodov, KH. Daminova (Tashkent, Uzbekistan)
Clinical–Radiological Correlation in Patients with brain calcifications: a case series

A. Ortiz Cardenas, F. Ramos, S. Rodriguez Quiroga, R. Piccioni, A. Tettamanti, M. Drnovsek, M. Nogueira, N. Garretto, T. Arakaki (CIUDAD DE BUENOS AIRES, Argentina)
Clinical, Neuropathological, and Functional Analysis of the Most Prevalent CSF1R Pathogenic Variant, p. Ile794Thr.

L. Milanowski, D. Liskey, M. Baker, A. Strongosky, D. Dickson, T. Kanekiyo, Z. Wszolek (Warsaw, Poland)
Clinician Guided Multimodal Kinematic AI System for Objective Assessment in Parkinson’s Disease

V. Tyagi, P. Silburn, Y. Pathak, D. Diaconescu (plano, USA)
Clinico-radiological Phenotype of a Unique Family with Mutations in PRKN Over Three Decades

M. Li, W. Liu, R. Mackinnon, C. Sue (Randwick, Australia)
Clinicodemographic characterization of Multiple System Atrophy in a multi-ethnic Malaysian cohort

JWY. Tee, AMF. Dy Closas, RJ. Neo, AL. Lee, AM. Abdul Sahak, YY. Beh, JP. Schee, P. Gengadharan, YW. Tay, TS. Toh, SH. Mat Desa, SY. Lim, N. Mohammad Ibrahim, AH. Tan (Kuala Lumpur, Malaysia)
Clinicogenetic Characterization of Sporadic Adult-Onset Ataxias in Austria

L. Schwaighofer, W. Nachbauer, M. Amprosi, D. Boesch, M. Schranz, R. Praschberger, A. Fanciulli, J. Wanschitz, S. Boesch, E. Indelicato (Innsbruck, Austria)
Closed-Loop Acoustic Neuromodulation for Functional Movement Disorder

B. Dukes, C. Tegeler, C. Tegeler, H. Munger Clary, K. Brown, M. Thenganatt, H. Shaltout, D. Shah-Zamora (Winston-Salem, USA)
Clustered Difference of Gut Microbiome in Helicobacter pylori-negative and positive Group Effect on Clinical Motor Symptoms in PD (Helicobacter pylori-Stool Microbiome or HP-SM Trial)

W. Wongpipathpong, N. Srivanitchapoom, M. Utharntharm, P. Pongchaikul, N. Tungtrongchitr (Samut Prakan, Thailand)
Cognition and Dementia in a Kenyan Parkinson’s Disease Cohort: A Sub-study of the TraPCAf Consortium

J. Nambafu, D. Sokhi, J. Hooker, M. Pambo, M. Parsemei, B. Mghendi (Nairobi, Kenya)
Cognitive & Clinical Correlates of Quality of Life in Probable Progressive Supranuclear Palsy

T. Leong, U. Ha, JY. Goh, R. Hoe, KY. Tay, WL. Au, L. Tan, A. Ng, S. Neo (Singapore, Singapore)
Cognitive and neuropsychiatric effects of home-based, remotely supervised strength exercise combined with guideline-based aerobic physical activity modification in Parkinson’s Disease: a randomized controlled trial

R. Kim, B. Byun, K. Kang, S. Choi, J. Lee, B. Jeon (Seoul, Republic of Korea)
Cognitive Effects of Low-Frequency STN-DBS in Parkinson’s Disease: A Systematic Review and Meta-Analysis

B. Meira, P. Bastos, V. Mendes Ferreira, J. Albuquerque, M. Magriço, R. Lemos, R. Barbosa, M. Coelho, M. Mendonça (Toulouse, France)
Cognitive Impairment and Agent Orange Exposure in Veterans with Essential Tremor.

R. Menodiado, D. Padilla, F. Jamal (Houston, USA)
Cognitive Impairment and Neuropsychiatric Manifestations in Parkinson’s disease in Africa: A Systematic Review of Evidence

M. Njohjam, F. Niakam, M. Ngoule (Dakar, Senegal)
Cognitive Profile In Indian Patients with Spinocerebellar Ataxia (SCA) – Prospective Cross-sectional Study

A. Patel, M. Bhatt, A. Aggarwal (Mumbai, India)
Cognitive profiles in idiopathic normal pressure hydrocephalus: clinical patterns and the impact of coexisting neurodegeneration

C. Espinoza-Vinces, I. Avilés-Olmos, G. Montoya-Murillo, J. Núñez-Córdoba, M. Luquin (Pamplona, Spain)
Cognitive Progression in Elderly Essential Tremor Patients: Evidence from an 18-Month Prospective Cohort

E. Abed (Cairo, Egypt)
Cognitive Safety and Stability in DBS for Parkinson’s Disease: Evidence for the Inclusion of Patients with Baseline Mild Cognitive Impairment.

JT. Martin, J. Sweet, A. Katewa, C. Bailey, C. Kilbane (Cleveland, USA)
Cognitive Trajectories After STN DBS in Parkinson’s Disease: 12-Month Outcomes

N. Austin, C. O'Keeffe, E. Reynolds, M. Garvey, F. Ruggieri, M. Kelly, C. Moran, R. Walsh (Dublin, Ireland)
Combination Device-aided therapy in Parkinson’s Disease

S. Garg, G. Chavira-Hernandez, R. Munhoz, T. Mestre (Ottawa, Canada)
Community Gym Exercise Therapy for People Living with Early Onset Parkinson’s Disease

C. Thwaites, M. Morris, D. Harris, M. Callisaya, R. Mouer, A. Clifford (Bundoora, Australia)
Comorbid Diabetes Exacerbates Motor and Nonmotor Dysfunction in Parkinson’s disease- a Cross-sectional Study

S. Krishnan, S. Veena, A. Vijayaraghavan, S. Sachithanandan, D. Puthenveedu (Thiruvananthapuram, India)
Comparability of Smartphone App and Booth Recordings for Robust Acoustic Speech Monitoring in Parkinson’s Disease

T. Thies, J. Strelow, D. Lopez, J. Tröger, I. Rubi-Fessen, M. Barbe, D. Mücke (Cologne, Germany)
Comparative Effectiveness of Tavapadon Versus Real-world Oral Standard of Care Treatments in Parkinson’s Disease With Motor Fluctuations: an Indirect Comparison Analysis

P. Agarwal, R. Pahwa, A. Fasano, H. Deng, C. Yan, L. Harmer, S. Huang, K. Onuk, A. Espay (Kirkland, USA)
Comparative efficacy and safety of Safinamide versus Opicapone in Japanese patients with Parkinson’s Disease and wearing-off: A matching-adjusted indirect comparison

N. Nishikawa, R. Ando, T. Ishida, T. Hatano, N. Hattori, M. Nomoto (Tokyo, Japan)
Comparative Efficacy of Wrist-Worn Non-Invasive Peripheral Nerve Stimulation for Essential Tremor: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Y. Abdalla, A. Mansour, K. Elsamman, Z. Helmy, T. Elboraay, Y. Negida, A. Salah, E. Moubarak, N. Hatem, Z. Tarek (Zagazig, Egypt)
Comparative Motor Response to Bilateral STN‑DBS in LRRK2‑Related and Idiopathic Parkinson’s Disease

J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)
Comparing Deep Brain Stimulation and MRI-Guided Focused Ultrasound Thalamotomy for Essential Tremor: A Single-Center, 1-Year Observational Study

E. Woo, T. Rafiq, B. Gupta, C. Jaimes, M. Ardila, P. Lawrence, K. Hunka, F. Girgis, C. Aquino (Calgary, Canada)
Comparison Of Levodopa Dose Frequency And Parkinson’s Kinetigraph Metrics For Screening Advanced Parkinson’s Disease

N. Ullah, H. Renduchintala, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)
Comparison of Motor Severity in Individuals with Drug-Induced Parkinsonism and Idiopathic Parkinson’s Disease A Systematic Review and Meta-Analysis

E. Maciel, T. da Rosa, F. Pereira, P. Nepomuceno, A. Pagnussat (Porto Alegre, Brazil)
Comparison of Neuroimaging-Derived and Clinical Motor Subtypes in Early Parkinson’s Disease

L. Saadatpour, A. Vijayakumari, K. Sakaei, D. Teixeira-Dos-Santos, H. Fernandez, B. Walter (San Antonio, USA)
Comparison of Non-Motor Outcomes after Subthalamic Nucleus versus Globus Pallidus Internus Deep Brain Stimulation in Parkinson’s disease

P. Borse, N. Balaini, M. Santhappan Girija, A. Hynse, A. Kishore (Kochi, India)
Comparison of Regional Perfusion Patterns in Clinical Subtypes of PSP and CBD: Dual Phase [¹⁸F]FP CIT PET Study

C. Lee, S. Kim, J. Ko, D. Doudet (Seongnam, Republic of Korea)
Comparison of Subcortical Brain Volumes in Different At-risk Cohorts of Parkinson’s Disease – Preliminary Data from the MUMFORD Study.

F. Jagusch, S. Leiter, A. Droby, A. Mirelman, K. Marini, C. Theyer, V. Sidoroff, C. Horlings, M. Aktan-Süzgün, A. Stefani, B. Högl, R. Steiger, A. Grams, E. Gizewski, C. Scherfler, B. Heim, K. Seppi, P. Mahlknecht, F. Krismer, A. Thaler (Innsbruck, Austria)
Compassion Focussed Therapy Groups for People with Parkinson’s and their care-partners

O. Batterbee, T. Edwards, B. Mohamed, J. Adenwalla, R. Lewis-Morton (Cardiff, United Kingdom)
Complete and sustained remission of cervical dystonia after repeated dual-target low-frequency rTMS (right M1 + left cerebellum): a 2-year follow-up case report

Y. Wu, M. Zhang, H. Sun, Z. Zheng, H. Shang (Chengdu, China)
Complete Resolution of Troublesome Dyskinesia in People With Advanced Parkinson’s Disease Treated With Foslevodopa/Foscarbidopa: Post Hoc Analysis From a 52-Week Phase 3 Trial

R. Hauser, A. Antonini, D. Di Luca, E. Freire-Alvarez, M. Oliveira Fernandes, M. Shah, L. Bergmann, X. Li, M. O’Meara, D. Standaert (Tampa, USA)
Complex FGF14 Repeat Expansion in Early-Onset Parkinson’s Disease

S. Song, Y. Yang, W. Wang, L. Liu (Jinan, China)
Complex Tics in a Child with Communicating Hydrocephalus: A Diagnostic Challenge

S. Immanni, A. Mehta, P. Hiremath, S. Furtado, P. R, M. Javali, P. Acharya (Bengaluru, India)
Complications Following Deep Brain Stimulation in Parkinson’s Disease: Single-centre Experience (2009-2025)

A. Kusnirova, S. Janovic, M. Kloc, P. Valkovic, Z. Kosutzka (Bratislava, Slovakia)
Comprehensive Cognitive Assessment Scales and APOE Gene Impact on Cognitive Function in Parkinson’s Disease: A Beijing Population Study

Z. Wu, X. Xue, A. Huang, E. Xu (Beijing, China)
Comprehensive Diagnostic Accuracy of α-Synuclein Seed Amplification Assays Across Non-Parkinsonian Synucleinopathies: A Systematic Review and Diagnostic Meta-analysis

P. Bhatele, P. Kukkle (Bangalore, India)
Comprehensive large-scale analysis of gene-environment interactions in Parkinson’s disease

D. Yang, W. Luo (Hangzhou, China)
Computer Vision for Quantitative Assessment of Posture and Instability in Parkinson’s Disease

G. Amprimo, C. Ferraris, S. Gallo, G. Imbalzano, M. Patera, M. Ghislieri, G. Olmo, A. Suppa, CA. Artusi (Turin, Italy)
Computer-Assisted Morphometric Analysis of Midbrain and Pons for Differential Diagnosis of Parkinsonian Disorders

P-W. Ko (Daegu, Republic of Korea)
Congenital Portosystemic Shunting: A Wilson’s Disease Mimic

L. Lei, K. Mhapankar, E. Tsochatzis, G. Gillett, S. Shribman, P. Korlipara (London, United Kingdom)
Considering Oral Health to Optimise the Potential for Current and Future Treatments in Parkinson’s Disease

J. Price, H. Martin (Powys, United Kingdom)
Consistent Motor Benefit of Safinamide across Clinically Relevant Subgroups in Japanese Patients with Parkinson’s Disease: A 24-Week Real-World Study

Y. Tsuboi, Y. Kogo, T. Ishida, K. Koizumi, M. Ishii (Tokyo, Japan)
Continued Evaluation of Clinical Outcomes in Participants With Parkinson’s Disease Through 4 Years After Bemdaneprocel Administration

C. Henchcliffe, H. Sarva, A. Fasano, A. Lozano, S. Kalia, KKH. Yu, C. Brennan, M. Louie-Gao, N. Floro, G. Belfort, V. Tabar (Toronto, Canada)
Continuous Subcutaneous Apomorphine Infusion in Parkinson Disease: Final Data from the Multi-Year InfusON Open-Label Extension Study

P. Lewitt, S. Isaacson, A. Espay, S. Reyes, A. Formella, G. Ceresoli-Borroni (Detroit, USA)
Continuous Subcutaneous Foslevodopa/Foscarbidopa After Deep Brain Stimulation or Levodopa–Carbidopa Intestinal Gel: A Case Series in Advanced Parkinson’s Disease

Y. Abdelmajid, M. Thomas, K. Waqar, E. de Freitas, R. Cabrito, R. Battah, A. Anjum, S. Om Mittal (Abu Dhabi, United Arab Emirates)
Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Advanced Parkinson’s Disease: Results from a Prospective Real-world Study

G. Pinola, V. Leta, M. Tosi, C. Leuzzi, F. Colucci, G. Gaudiano, A. Braccia, F. Pirone, S. Rinaldo, R. Cancilla, N. Golfrè Andreasi, L. Romito, G. Devigili, R. Cilia, AE. Elia, R. Eleopra (Milano, Italy)
Continuous subcutaneous levodopa infusion in advanced Parkinson’s disease: a descriptive real-world cohort study

P. Prendes Fernandez, P. Tartiere Gonzalez, E. Suarez Sanmartin, C. Garcia Fernandez, L. Gonzalez Alvarez, M. Blazquez Estrada (Oviedo, Spain)
Continuous Subcutaneous Levodopa Therapy Improves Motor Fluctuations and Quality of Life in Parkinson’s Disease: Evidence from Meta-analysis of Clinical Trials

K. Sarhan (Mansoura, Egypt)
Contribution of blood lipid profile to long-term outcome in idiopathic normal pressure hydrocephalus

J. Bissacco, D. Mascioli, C. Simonetta, M. Mancini, V. Buttarazzi, M. Conti, F. Veltri, S. Bagetta, M. Pierantozzi, A. Stefani, F. Buttari, D. Centonze, A. Pesce, M. Pieri, S. Borrelli, F. Di Giuliano, T. Schirinzi (Pozzilli, Italy)
Correlating Start Hesitation and Subthalamic Nucleus Activity in Parkinson’s Disease Using Intraoperative Microelectrode Recordings and a Virtual Reality Task

C. Coppin, M. Georgiades, S. Lewis (Macquarie Park, Australia)
Correlation Analysis of Cortical Activation and Aspiration Risk During Swallowing in Patients with Multiple System Atrophy

YF. Xia, B. Xiong, P. Wang, N. Chen, W. Luo (Hangzhou, China)
Correlation Between Daily Vitamin Intake and Clinical Severity of Parkinson’s in Northeastern Mexico: An Exploratory Study

R. Trejo-Ayala, P. Ancer-Rodríguez, M. Herrera-López, K. Chapa-Ancer, J. Bermudes-Mendoza, A. Trejo-Ayala, R. Enriquez-Menchaca, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)
Correlation between handwriting and cognitive function in patients with Parkinson’s disease

S. Obika, O. Montero, J. Ortega, M. Escribano, A. Ruiz-Yanzi, C. Del Toro, E. Natera-Villalba, C. Gasca-Salas, M. Matarazzo, R. Martínez-Fernández, F. Alonso-Frech (Madrid, Spain)
Correlational Study of the Clinical Impression of Severity Index for Parkinson’s Disease (CISI-PD) with Functional Mobility Measures

ZE. Chan, KCY. Yong, KP. Lim, JP. Chua, TS. Toh, AH. Tan, SY. Lim (Subang Jaya, Malaysia)
Correlations Between Clinical Variables And Cerebral Perfusion in Parkinson’s Disease With Mild Cognitive Impairment: A Multi-Delay pcASL Study

N. Chaurasiya, G. Rathi, V. Mishra (Birmingham, USA)
Cortical Disinhibition and Beta Hypersynchrony underlying Freezing of Gait in Parkinson’s Disease: a TMS–EEG Study

HM. Sun, KZ. Zhang (Nanjing, China)
Cortical Dynamics Underlying the Heterogeneous Dopamine Responsiveness of Rest Tremor in Parkinson’s Disease

X. Xu, Y. Zang, P. Chan (Beijing, China)
Cortical Mean Diffusivity as a Measure of Microstructural Neurodegeneration in Multiple System Atrophy

J. Pardo, V. Montal, C. Martín-Barceló, I. Roura, C. García-Vicente, C. Falcon, A. Campabadal, R. Sala-Llonch, N. Bargalló, J. Fortea, C. Painous, A. Pérez, A. Cámara, Y. Compta, C. Junqué, B. Segura, MJ. Martí (Barcelona, Spain)
Cortical Oscillatory Dynamics during Turning in Parkinson’s Disease using OPM-MEG

P. Sharma, B. Sanders, C. Gilmartin, L. Rier, L. Gascoyne, J. Leggett, I. Tu, M. Dabbagh, H. Pai, L. Eriamietor, N. Holmes, R. Hill, E. Boto, A. Hibbert, H. Schofield, K. Mullinger, K. Radford, A. Fasano, M. Brookes, N. Evangelou (Nottingham, United Kingdom)
Cortical–Subcortical Structural Signature of dementia with lewy bodies Reveals Cognitive Trajectories of Lewy Body Disease in REM Sleep Behavior Disorder

JH. Shin, HJ. Kim, JY. Lee (Seoul, Democratic People's Republic of Korea)
Corticobasal Degeneration With Alien Limb Phenomenon and Severe Cognitive Decline: A Levodopa-Resistant Clinical Case

N. Aripova, B. Muhammedaminov, Y. Nishonova, L. Kenjaeva (Tashkent, Uzbekistan)
Corticobasal Syndrome: A Single-Center Retrospective Review

E. Krening, T. Kaneko, M. Bruno (Honolulu, USA)
Coupling between global BOLD signal and cerebrospinal fluid flow in isolated REM sleep behavior disorder and its relation with non-motor symptoms.

C. Martín-Barceló, I. Roura, R. Sala-Llonch, C. Falcon, J. Pardo, C. Garcia-Vicente, L. Pacheco-Jaime, N. Bargalló, M. Serradell, G. Mayà, A. Montini, M. Buongiorno, C. Gaig, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)
Coupling of Cholinergic and Dopaminergic Terminal Loss in Progressive Supranuclear Palsy: A Multimodal [18F]FEOBV and [11C]PE2I Study

P. Kanel, G. Carli, S. Roytman, J. Barr, R. Vangel, A. van Hout, C. Spears, P. Scott, R. Albin, N. Bohnen (Ann. Arbor, USA)
Creative Engagement as a Unique Lens on Quality of Care in Parkinson’s Disease

S. Zeggio, B. Post, J. Koksma, B. Bloem, B. Spee (Nijmegen, Netherlands)
Creutzfeldt Jakob Disease Miming a Cortico-basal syndrome: does it exist?

Y. Memmich, R. Zouari, D. Bn Mohamed, Z. Saied, A. Rachdi, F. Nabli, S. Ben Sassi (tunis, Tunisia)
Cross-Continental Differences in Prodromal Symptoms of Lewy Body Dementia: A Comparative Analysis Across Asia, Europe, and North America

C. Hu, N. Nguyen (San Antonio, USA)
Cross-Cultural Validation of the Hebrew version of The International Parkinson and Movement Disorder Society Non-Motor Rating Scale

VL. Livneh, A. Ezra, H. Lentschitzky, A. Socher, A. Thaler, A. Hilel, H. Shabtai, J. Zitser, G. Eshed, T. Shainer, P. Ponger, R. Alcalay, Y. Manor, V. Rozani, S. Luo, C. Goetz, G. Stebbins, P. Martin, T. Mestre, A. Ferro (Tel Aviv, Israel)
Cross-Family Analysis of Rare Deleterious Variants Segregating in Families with Parkinson’s Disease

C. Gabbert, T. Kleinz, B. Bustos, C. Blauwendraat, SY. Lim, AH. Tan, A. Ahmad-Annuar, YW. Tay, B. Tserensodnom, A. Zimprich, CH. Lin, RRM. Wu, EM. Valente, M. Avenali, SU. Rehman, ZH. Fang, P. Heutink, C. Klein, N. Mencacci, J. Trinh (Chicago, USA)
Cross-Sectional and Longitudinal MRI Biomarkers of Neurodegeneration in Friedreich’s Ataxia

R. Sutil Berjón, L. Manrique, F. Martínez Dubarbie, A. Pelayo Negro, N. Benitez Calle, M. Sánchez Pelaez, D. Cota González, R. Loza Palacios, R. Martínez Díaz, C. Sánchez Quintana, I. Sánchez, A. Matilla Dueñas, D. Castanedo Vázquez, M. Drake Pérez, E. Marco, C. Biarnés Duran, E. Dela Calle, J. Infante (Santander, Spain)
Cross-trait and Multi-polytranscriptomic Score Prediction of Parkinson’s Disease

L. Gilchrist, O. Pain, S. Calhas, GP2. Genetics Program, A. Noyce, K. Brolin, T. Periñan, P. Proitsi (London, United Kingdom)
Cryptococcal Meningitis Presenting with Lower Body Parkinsonism and Generalized Chorea: A Case Report

S. Songwisit, P. Boonumnuay, Y. Pitakpatapee, W. Saengphatrachai (Bangkok, Thailand)
Current Landscape and Unmet Needs of Neuropallitive-Supportive Care for Parkinson’s Disease in Korea: A Multicenter Survey of Patients, Caregiver, and Physicians

C. Lee, M. Kim, Y. Hwang, J. Lee, K. Park, H. Chang, S. Lee, H. Kim, S. You, J. Yun (Seoul, Republic of Korea)